Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.
about
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and woundsMolecular predictors of 3D morphogenesis by breast cancer cell lines in 3D cultureQuantitative proteomic profiling identifies DPYSL3 as pancreatic ductal adenocarcinoma-associated molecule that regulates cell adhesion and migration by stabilization of focal adhesion complexGenome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in AsiaCLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells.Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genesEGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line.ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis.Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmaticsThe neuropilin-like protein ESDN regulates insulin signaling and sensitivity.Semaphorins and their receptors in lung cancer.Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination.A fast algorithm for Bayesian multi-locus model in genome-wide association studies.Identification of novel neuroendocrine-specific tumour genes.Long signal peptides of RGMa and DCBLD2 are dissectible into subdomains according to the NtraC model.Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2.Pancreatic cancer survival analysis defines a signature that predicts outcome
P2860
Q21146433-28E34250-B654-4853-983E-F6F8F4745230Q28473032-FCC93ECF-2F1D-4E59-83FE-785BA8A493E2Q28536191-5D5634F8-08E0-4C76-A7F5-99B59E17F730Q28943345-8AB984DD-F6D7-44DF-82BB-DBF67DAC1D60Q33268742-3A5B6124-BEF2-4590-8B30-20ECDAE6823BQ33595109-AB396D48-2965-4F4C-93B5-11406B2CBFFFQ34117589-0600E221-3216-440E-8D10-A98C41635DD2Q34258443-F2F74869-0C5D-4149-BE20-D4C45F1C1A37Q34662862-E2BF019B-A848-4DEB-AA08-F716F9EEC0B5Q35859198-C21ADE04-2613-48A0-ABBC-B329D404A334Q36902569-206633E9-EC11-4AD2-9035-FBA454BC0235Q37072227-6E5C373B-9467-4212-9C9A-A45B5A99AD73Q37384099-1E916262-9214-4E80-BA5B-505CFE9F00BAQ37447644-9DE1E8C6-FF3C-4E92-8BCA-39B0CE29098AQ38769625-DEBE3CB0-CFC9-4D5B-BB72-F495108C82EAQ39933886-D8EFDD2E-B0E6-49FD-A8FD-EF784CA23732Q45754540-A2C42676-0769-4D71-9751-9D394BA382ECQ47660230-9185CF3B-2780-4EA0-B0D7-1D0CBC8DD501Q57136038-54AD2141-053A-4FE1-8859-9AA576D603AA
P2860
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@ast
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@en
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@nl
type
label
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@ast
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@en
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@nl
prefLabel
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@ast
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@en
Significant up-regulation of a ...... ll as in lung cancers in vivo.
@nl
P2093
P356
P1433
P1476
Significant up-regulation of a ...... ell as in lung cancers in vivo
@en
P2093
Akimasa Nakao
Akira Masuda
Hirotaka Osada
Katsumi Koshikawa
Ken-Ichi Kozaki
Tetsuya Mitsudomi
Yoshio Tatematsu
P2888
P304
P356
10.1038/SJ.ONC.1205405
P407
P577
2002-04-01T00:00:00Z
P5875
P6179
1008027439